GEODE CAPITAL MANAGEMENT, LLC - QUALIGEN THERAPEUTICS INC ownership

QUALIGEN THERAPEUTICS INC's ticker is QLGN and the CUSIP is 74754R103. A total of 18 filers reported holding QUALIGEN THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of QUALIGEN THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$60,000
-53.5%
226,6710.0%0.00%
Q2 2022$129,000
-7.9%
226,671
+6.6%
0.00%
Q1 2022$140,000
-38.3%
212,6240.0%0.00%
Q4 2021$227,000
-20.9%
212,624
-3.9%
0.00%
Q3 2021$287,000
-14.3%
221,146
+31.1%
0.00%
Q2 2021$335,000
-18.7%
168,702
+10.3%
0.00%
Q1 2021$412,000
+11.4%
152,898
+24.3%
0.00%
Q4 2020$370,000
+12.8%
123,035
+85.6%
0.00%
Q3 2020$328,00066,3060.00%
Other shareholders
QUALIGEN THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
CRA Financial Services, LLC 19,957$60,0000.02%
OCCUDO QUANTITATIVE STRATEGIES LP 15,800$48,0000.02%
WEDBUSH SECURITIES INC 32,228$97,0000.01%
QS Investors, LLC 82,000$247,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 62,500$188,0000.00%
Retirement Group, LLC 2,500$7,0000.00%
Cetera Investment Advisers 40,275$121,0000.00%
Your Advocates Ltd., LLP 200$1,0000.00%
UBS Group AG 2,467$7,0000.00%
IFP Advisors, Inc 0$00.00%
View complete list of QUALIGEN THERAPEUTICS INC shareholders